MedWaves Inc. received FDA 510(k) clearance in January 2008 for its patented Microwave Coagulation/Ablation System for ...
Between 44,000 and 98,000 Americans die each year from preventable medical errors, according to the Institute of ...
Baxa Corp. launched the MedBoard Web-based medication tracking system in December 2007, designed to record pharmacy ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
There has been a flood of new products and a rush by companies to get new infection control products on the market since last summer, when the Centers for Medicare and Medicaid Services (CMS) passed a rule it will no longer reimburse healthcare facilities for preventable hospital-acquired infections (HAIs) starting in October 2008.
April 9, 2008 - Michigan Instruments Inc. recently launched its new life support device, Life-Stat, that provides ...
Monitoring system maker Mennen Medical recently said an additional monitor, the VitaLogik 4000 Series, will soon be ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Medrad hopes to thrust new life into molecular imaging with its 510(k) pending FDG-PET power injector system called Intego, designed to promote greater accuracy in dose injection and which reportedly reduces radiation exposure related to FDG-handling by 40 percent.
April 8, 2008 - Doctors at Boston Medical Center (BMC) led by Chief of Cardiac Surgery Robert Poston, M.D., have been ...
April 8, 2008 - People who are taking three or more drugs and still have high blood pressure have a condition known as ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
The Philips HD7 is a high-volume ultrasound system used in cardiovascular, OB/GYN, anesthesiology, oncology, electrophysiology, stress echo, pediatric, orthopedic, urologic, emergency and other applications.
April 8, 2008 - Atrial fibrillation demonstrated that a port access, paracardioscopic Ex-Maze procedure produced favorable outcomes and allowed patients to discontinue antiarrhythmic drugs, according to interim results from a study presented by Andy C. Kiser, M.D., at the American College of Cardiology meeting in Chicago, IL.
April 8, 2008 - The first-in-man study funded by MIV Therapeutics Inc. (MIV) showed that MIV's VESTAsync stents ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
April 8, 2008 - Battelle, a nonprofit independent research and development organization, and MEDRAD Inc. won a Medical ...
April 8, 2008 - The government on Monday said it would raise payments next year to insurers that provide healthcare ...
MEDRAD Inc. won a Medical Design Excellence Award (MDEA) for the MEDRAD XDS Extravasation Detector, a device for the ...
April 08, 2008
